Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBX129801 in type 1 diabetes mellitus
NCT01293461Phase 2Completed
- Sponsor
- Cebix
- Start
- Apr 2011
- Primary completion
- Aug 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Pegylated synthetic human C-peptide in diabetic peripheral neuropathy (DPN), sponsored by Cebix. Started Apr 2011; status: completed.
02
Drugs
Pegylated synthetic human C-peptide
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01293461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01293461.